Viking Therapeutics: Pemain GLP-1 Misterius Dengan Katalis Utama (Laba Kuartal II) (VKTX)
· seekingalpha.com
Saham Viking Therapeutics bertahan seiring memanasnya persaingan obat obesitas GLP-1. Baca analisis terbaru mengenai laporan laba di sini.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...